financetom
Business
financetom
/
Business
/
BRIEF-byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination
Jan 10, 2025 2:51 PM

Jan 10 (Reuters) - Bynordic Acquisition Corp ( BYNO ):

* BYNORDIC ACQUISITION CORPORATION ANNOUNCES EXTENSION OF

DEADLINE

TO COMPLETE BUSINESS COMBINATION

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Victoria's Secret Turnaround Progress Slower Than Expected, Morgan Stanley Says
Victoria's Secret Turnaround Progress Slower Than Expected, Morgan Stanley Says
Mar 7, 2025
11:26 AM EST, 03/07/2025 (MT Newswires) -- Victoria's Secret's (VSCO) Q1 and full-year outlook were disappointing amid expectations that turnaround progress will be delayed until H2 or early 2026, which is a bit slower than expected, Morgan Stanley said in a note emailed Friday. Morgan Stanley said that the guidance assumes gradual macroeconomic improvement, increased marketing investment, better product differentiation,...
Canada suspends imports from biggest US pork processing plant
Canada suspends imports from biggest US pork processing plant
Mar 7, 2025
CHICAGO (Reuters) - Canada has suspended imports from the biggest U.S. pork processing plant, a facility run by Smithfield Foods ( SFD ) in Tar Heel, North Carolina, the company said on Friday. The suspension comes as the U.S. and Canada have engaged in a heated dispute over trade tariffs. Smithfield is working with the USDA to resolve the matter,...
Oruka Therapeutics Says ORKA-002 Preclinical Data Support Potential Extended Dosing Intervals
Oruka Therapeutics Says ORKA-002 Preclinical Data Support Potential Extended Dosing Intervals
Mar 7, 2025
11:25 AM EST, 03/07/2025 (MT Newswires) -- Oruka Therapeutics ( ORKA ) said Friday that preclinical data on its monoclonal antibody ORKA-002 support potential extended dosing intervals and show equivalent potency to bimekizumab in plaque psoriasis. The company said ORKA-002 demonstrated a half-life of over 30 days in non-human primates, more than three times longer than bimekizumab and indicating a...
--Vertiv Keeps Quarterly Dividend at $0.0375 a Share, Payable March 27 to Holders of Record March 18
--Vertiv Keeps Quarterly Dividend at $0.0375 a Share, Payable March 27 to Holders of Record March 18
Mar 7, 2025
11:21 AM EST, 03/07/2025 (MT Newswires) -- Price: 80.96, Change: -1.09, Percent Change: -1.32 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved